Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

ABRILADA - 40mg - 2

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L04AB04 BioTech Adalimumab - 40mg 11325 147822/1 ABRILADA 40mg 2 Injectable solution SC Food & Drug Corporation FDC Catalent Indiana, LLC USA 40,259,574 L.L 10.71 E1 Pfizer Europe MA EEIG Belgium 2/5/2024 0

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L04AB04 BioTech Adalimumab - 40mg 11326 147922/1 ABRILADA 40mg 2 Injectable solution SC Food & Drug Corporation FDC Catalent Indiana, LLC USA 40,259,574 L.L 10.71 E1 Pfizer Europe MA EEIG Belgium 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg 11585 106523/1 ADALIREL 40mg 1x0.8ml Injectable solution SC Levant Pulse SARL Reliance Life Sciences pvt Ltd India 15,102,158 L.L 19.35 D Reliance Life Sciences pvt Ltd India 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg/0.8ml 9616 149418/1 AMGEVITA 40mg/0.8ml 2 x 0.8ml Injectable solution SC Mersaco Amgen Manufacturing Ltd USA 637,324 L.L 10.71 E1 Amgen Europe BV The Netherlands 2/5/2024
L04AB04 BioTech Adalimumab - 40mg/0.8ml 9617 149318/1 AMGEVITA 40mg/0.8ml 2 x 0.8ml Injectable solution SC Mersaco Amgen Manufacturing Ltd USA 637,324 L.L 10.71 E1 Amgen Europe BV The Netherlands 2/5/2024
L04AB04 BioTech Adalimumab - 40mg/0.8ml 10085 125519/1 CINNORA 40mg/0.8ml 2 Injectable solution SC Lebiran SARL Cinnagen Co Iran 14,817,734 L.L 19.35 D Cinnagen Co Iran 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg/0.4ml 9597 135418/1 HUMIRA 40mg/0.4ml 2 x 0.4ml Injectable solution SC Interpharma S.A.L. Vetter Pharma- Fertigung GmbH & Co KG Germany 33,860,031 L.L 10.71 E1 Abbvie Deutschland GmbH & Co KG Germany 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg 9748 41219/1 HYRIMOZ 40mg 2 Injectable solution SC Khalil Fattal & Fils S.A.L. Sandoz GmbH, (Schaftenau) Austria 682,013 L.L 10.71 E1 Sandoz GmbH, Kundl Austria 2/5/2024
L04AB04 BioTech Adalimumab - 40mg 9749 41119/1 HYRIMOZ 40mg 2 Injectable solution SC Khalil Fattal & Fils S.A.L. Sandoz GmbH, (Schaftenau) Austria 682,013 L.L 10.71 E1 Sandoz GmbH, Kundl Austria 2/5/2024
L04AB04 BioTech Adalimumab - 40mg/0.8ml 9616/945 149418/1 AMGEVITA 40mg/0.8ml 2 x 0.8ml Injectable solution SC Mersaco Amgen Manufacturing Ltd USA 38,855,434 L.L 10.71 E1 Amgen Europe BV The Netherlands 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg/0.8ml 9617/945 149318/1 AMGEVITA 40mg/0.8ml 2 x 0.8ml Injectable solution SC Mersaco Amgen Manufacturing Ltd USA 38,855,434 L.L 10.71 E1 Amgen Europe BV The Netherlands 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg 9748/945 41219/1 HYRIMOZ 40mg 2 Injectable solution SC Khalil Fattal & Fils S.A.L. Sandoz GmbH, (Schaftenau) Austria 26,715,144 L.L 10.71 E1 Sandoz GmbH, Kundl Austria 2/5/2024 0
L04AB04 BioTech Adalimumab - 40mg 9749/945 41119/1 HYRIMOZ 40mg 2 Injectable solution SC Khalil Fattal & Fils S.A.L. Sandoz GmbH, (Schaftenau) Austria 26,715,144 L.L 10.71 E1 Sandoz GmbH, Kundl Austria 2/5/2024 0
Sitemap
© Copyrights reserved to Ministry of Public Health 2024